These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31434474)

  • 21. New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii.
    Minrovic BM; Jung D; Melander RJ; Melander C
    ACS Infect Dis; 2018 Sep; 4(9):1368-1376. PubMed ID: 29890069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
    Evans ME; Feola DJ; Rapp RP
    Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS; Rhomberg PR; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):379-81. PubMed ID: 26415906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Bromoindirubin-3'-oxime derivatives are highly active colistin adjuvants against
    Li H; Mattingly AE; Smith RD; Melander RJ; Ernst RK; Melander C
    RSC Med Chem; 2023 Feb; 14(2):247-252. PubMed ID: 36846374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in-vitro activity of colistin in gram-negative bacteria.
    Tan TY; Ng SY
    Singapore Med J; 2006 Jul; 47(7):621-4. PubMed ID: 16810437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
    Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
    Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Otilonium bromide boosts antimicrobial activities of colistin against Gram-negative pathogens and their persisters.
    Xu C; Liu C; Chen K; Zeng P; Chan EWC; Chen S
    Commun Biol; 2022 Jun; 5(1):613. PubMed ID: 35729200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro Efficacy of Meropenem, Colistin and Tigecycline Against the Extended Spectrum Beta-Lactamase Producing Gram Negative Bacilli.
    Gill MM; Usman J; Hassan A; Kaleem F; Anjum R
    J Coll Physicians Surg Pak; 2015 May; 25(5):342-5. PubMed ID: 26008659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications.
    Sherry N; Howden B
    Expert Rev Anti Infect Ther; 2018 Apr; 16(4):289-306. PubMed ID: 29543500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria.
    Dokla EME; Abutaleb NS; Milik SN; Li D; El-Baz K; Shalaby MW; Al-Karaki R; Nasr M; Klein CD; Abouzid KAM; Seleem MN
    Eur J Med Chem; 2020 Jan; 186():111850. PubMed ID: 31735572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing the Hedgehog pathway inhibitor, BMS-833923, as a phosphatidylglycerol-selective membrane-disruptive colistin adjuvant against ESKAPE pathogens.
    Zhang N; Shan W; Gao L; Kou SH; Lu C; Yang H; Peng B; Tam KY; Lee LTO; Zheng J
    Int J Antimicrob Agents; 2023 Sep; 62(3):106888. PubMed ID: 37328075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of sensi-disk elution for colistin susceptibility determination in multidrug resistant gramnegative bacilli].
    Jofré M; Barrera B; Silva F; Berrocal L
    Rev Chilena Infectol; 2020 Feb; 37(1):87-88. PubMed ID: 32730406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial properties of erythromycin and colistin impregnated bone cement. An in vitro analysis.
    Ruzaimi MY; Shahril Y; Masbah O; Salasawati H
    Med J Malaysia; 2006 Feb; 61 Suppl A():21-6. PubMed ID: 17042224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.